NKT cells, Treg, and their interactions in bone marrow transplantation

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1862-1869

  Kohrt, Holbrook E ^a   Pillai, Asha B ^b   Lowsky, Robert ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Natural killer T cells; Regulatory T cells

Indexed keywords

T LYMPHOCYTE ANTIBODY; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CONDITIONING; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; LYMPH NODE IRRADIATION; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; DISEASE MODEL; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; MEDICAL RESEARCH; METABOLISM; MOUSE; NATURAL KILLER T CELL;

ANIMALS; ANTIGENS, CD4; BIOMEDICAL RESEARCH; BONE MARROW TRANSPLANTATION; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HUMANS; IMMUNOMODULATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 77954104148     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040394     Document Type: Review

References (71)

1. Hart, D. P. and Peggs, K. S., Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies. Clin. Pharmacol. Ther. 2007. 82: 325-329.
2. Koreth, J., Schlenk, R., Kopecky, K. J., Honda, S., Sierra, J., Djulbegovic, B. J., Wadleigh, M. et al., Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. J. Am. Med. Assoc. 2009. 301: 2349-2361.
3. Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G., Fielding, A. K., Burnett, A. K. et al., In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008. 111: 1827-1833.
4. Alyea, E., Weller, E., Schlossman, R., Canning, C., Mauch, P., Ng, A., Fisher, D. et al., Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Bone Marrow Transplant. 2003. 32: 1145-1151.
5. Zuckerman, T. and Rowe, J. M., Hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia. Curr. Opin. Hematol. 2009. 16: 453-459.
6. Maris, M. B., Niederwieser, D., Sandmaier, B. M., Storer, B., Stuart, M., Maloney, D., Petersdorf, E. et al., HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003. 102: 2021-2030.
7. Mielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E., Maloney, D. G., Sandmaier, B. M., Maris, M. B. and Storb, R., Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003. 102: 756-762. (Pubitemid 36842003)
8. Kohrt, H. E., Turnbull, B. B., Heydari, K., Shizuru, J. A., Laport, G. G., Miklos, D. B., Johnston, L. J. et al., TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 2009. 114: 1099-1109.
9. Marks, D. I., Lush, R., Cavenagh, J., Milligan, D. W., Schey, S., Parker, A., Clark, F. J. et al., The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 2002. 100: 3108-3114.
10. Martino, R., Caballero, M. D., Perez-Simon, J. A., Canals, C., Solano, C., Urbano-Ispizua, A., Bargay, J. et al., Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Blood 2002. 100: 2243-2245.
11. Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M. et al., Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007. 110: 433-440.
12. Choi, S.W., Levine, J. E. and Ferrara, J. L., Pathogenesis and management of graft-versus-host disease. Immunol. Allergy Clin. North Am. 2010. 30: 75-101.
13. Boeckh, M., Erard, V., Zerr, D. and Englund, J., Emerging viral infections after hematopoietic cell transplantation. Pediatr. Transplant. 2005. 9: 48-54.
14. Bunjes, D., The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML. Cytotherapy 2001. 3: 175-188. (Pubitemid 33039655)
15. Kolb, H. J., Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008. 112: 4371-4383.
16. Sprangers, B., Fevery, S., VanWijmeersch, B., De Somer, L.,Waer, M. and Billiau, A. D., Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease? Front. Biosci. 2007. 12: 4568-4594.
17. Palathumpat, V., Dejbakhsh-Jones, S., Holm, B., Wang, H., Liang, O. and Strober, S., Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity. J. Immunol. 1992. 148: 373-380.
18. Zeng, D., Lewis, D., Dejbakhsh-Jones, S., Lan, F., Garcia-Ojeda, M., Sibley, R. and Strober, S., Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 1999. 189: 1073-1081.
19. Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S. and Negrin, R. S., CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 2003. 9: 1144-1150.
20. Kronenberg, M. and Kinjo, Y., Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 2009. 21: 391-396.
21. Kronenberg, M. and Engel, I., On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr. Opin. Immunol. 2007. 19: 186-193.
22. Kronenberg, M., Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005. 23: 877-900.
23. Kronenberg, M. and Gapin, L., The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002. 2: 557-568.
24. Yao, Z., Liu, Y., Jones, J. and Strober, S., Differences in Bcl-2 expression by T-cell subsets alter their balance after in vivo irradiation to favor CD4+ Bcl-2hi NKT cells. Eur. J. Immunol. 2009. 39: 763-775.
25. Nador, R. G., Hongo, D., Yao, Z. and Strober, S., The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am. J. Transplant. 2009: e-publication 20041865.
26. Zeng, D., Hoffmann, P., Lan, F., Huie, P., Higgins, J. and Strober, S., Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood 2002. 99: 1449-1457.
27. Zeng, D., Gazit, G., Dejbakhsh-Jones, S., Balk, S. P., Snapper, S., Taniguchi, M. and Strober, S., Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. J. Immunol. 1999. 163: 5338-5345.
28. Palathumpat, V., Dejbakhsh-Jones, S., Holm, B. and Strober, S., Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease. J. Immunol. 1992. 149: 808-817.
29. Sykes, M., Hoyles, K. A., Romick, M. L. and Sachs, D. H., In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines. Cell. Immunol. 1990. 129: 478-493.
30. Strober, S., Cheng, L., Zeng, D., Palathumpat, R., Dejbakhsh-Jones, S., Huie, P. and Sibley, R., Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity. Immunol. Rev. 1996. 149: 217-230.
31. Fowler, D. H., Kurasawa, K., Husebekk, A., Cohen, P. A. and Gress, R. E., Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J. Immunol. 1994. 152: 1004-1013.
32. Krenger, W., Snyder, K. M., Byon, J. C., Falzarano, G. and Ferrara, J. L., Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 1995. 155: 585-593.
33. Fowler, D. H., Breglio, J., Nagel, G., Eckhaus, M. A. and Gress, R. E., Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol. 1996. 157: 4811-4821.
34. Levings, M. K., Sangregorio, R. and Roncarolo, M. G., Human cd25(+)cd4(+) t regulatory cells suppress naive andmemory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001. 193: 1295-1302.
35. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
36. Kang, S. M., Tang, Q. and Bluestone, J. A., CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am. J. Transplant. 2007. 7: 1457-1463.
37. Taylor, P. A., Noelle, R. J. and Blazar, B. R., CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 2001. 193: 1311-1318.
38. Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G. and Strober, S., Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 2002. 196: 389-399.
39. Snider, D. and Liang, H., Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction. J. Immunol. 2001. 166: 5991-5999. (Pubitemid 32440723)
40. Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., Barbosa, T. C., Cumano, A. and Bandeira, A., CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 2001. 166: 3008-3018.
41. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A., Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol. 2002. 3: 33-41.
42. Slavin, S. and Strober, S., Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR). J. Immunol. 1979. 123: 942-946.
43. Kaplan, H. S. and Rosenberg, S. A., Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials. Cancer Res. 1966. 26: 1268-1276.
44. Slavin, S., Fuks, Z., Kaplan, H. S. and Strober, S., Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J. Exp. Med. 1978. 147: 963-972.
45. Gottlieb, M., Strober, S., Hoppe, R. T., Grumet, F. C. and Kaplan, H. S., Engraftment of allogeneic bone marrow without graft-versus-host disease in mongrel dogs using total lymphoid irradiation. Transplantation 1980. 29: 487-491.
46. King, D. P., Strober, S. and Kaplan, H. S., Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI). J. Immunol. 1981. 126: 1140-1145. (Pubitemid 11155769)
47. Lan, F., Zeng, D., Higuchi, M., Huie, P., Higgins, J. P. and Strober, S., Predominance of NK1.1+TCR alpha beta1 or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol. 2001. 167: 2087-2096.
48. Field, E. H. and Rouse, T. M., Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses. Transplantation 1995. 60: 695-702.
49. Lan, F., Zeng, D., Higuchi, M., Higgins, J. P. and Strober, S., Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant. 2003. 9: 355-363.
50. Liu, Y. P., Li, Z., Nador, R. G. and Strober, S., Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells. Transplantation 2008. 85: 607-614.
51. Pillai, A. B., George, T. I., Dutt, S., Teo, P. and Strober, S., Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J. Immunol. 2007. 178: 6242-6251.
52. Seino, K. and Taniguchi, M., Functionally distinct NKT cell subsets and subtypes. J. Exp. Med. 2005. 202: 1623-1626.
53. Pillai, A. B., George, T. I., Dutt, S. and Strober, S., Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+ Foxp3+ T regulatory cells that protects against graft-versus-host disease. Blood 2009. 113: 4458-4467.
54. Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., et al., Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 2006. 177: 5852-5860.
55. Liu, R., La Cava, A., Bai, X. F., Jee, Y., Price, M., Campagnolo, D. I., Christadoss, P. et al., Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J. Immunol. 2005. 175: 7898-7904.
56. Jiang, S., Game, D. S., Davies, D., Lombardi, G. and Lechler, R. I., Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+ CD25+ regulatory T cells? Eur. J. Immunol. 2005. 35: 1193-1200.
57. Maris, M. B., Sandmaier, B. M., Storer, B. E., Chauncey, T., Stuart, M. J., Maziarz, R. T., Agura, E. et al., Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 2004. 104: 3535-3542.
58. Georges, G. E., Maris, M., Sandmaier, B. M., Malone, D. G., Feinstein, L., Niederweiser, D., Shizuru, J. A. et al., Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int. J. Hematol. 2002. 76: 184-189.
59. Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., Grumet, F. C., Shizuru, J. A., Laport, G. G. et al., Protective conditioning for acute graft-versus-host disease. N. Engl. J. Med. 2005. 353: 1321-1331.
60. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G. et al., Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998. 91: 756-763. (Pubitemid 28078275)
61. Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E. J. et al., Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999. 94: 3234-3241.
62. Giralt, S., Thall, P. F., Khouri, I., Wang, X., Braunschweig, I., Ippolitti, C., Claxton, D. et al., Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001. 97: 631-637.
63. McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R. et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001. 97: 3390-3400.
64. Niederwieser, D., Maris, M., Shizuru, J. A., Petersdorf, E., Hegenbart, U., Sandmaier, B.M., Maloney, D. G. et al., Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003. 101: 1620-1629.
65. Schetelig, J., Kroger, N., Held, T. K., Thiede, C., Krusch, A., Zabelina, T., Dubiel, M. et al., Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. Haematologica 2002. 87: 299-305. (Pubitemid 34212447)
66. Spitzer, T. R., McAfee, S., Sackstein, R., Colby, C., Toh, H. C., Multani, P., Saidman, S. et al., Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol. Blood Marrow Transplant. 2000. 6: 309-320.
67. Miklos, D. B., Kim, H. T., Miller, K. H., Guo, L., Zorn, E., Lee, S. J., Hochberg, E. P. et al., Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005. 105: 2973-2978.
68. Nguyen, V. H., Zeiser, R., Dasilva, D. L., Chang, D. S., Beilhack, A., Contag, C. H. and Negrin, R. S., In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 2007. 109: 2649-2656.
69. Ermann, J., Hoffmann, P., Edinger, M., Dutt, S., Blankenberg, F. G., Higgins, J. P., Negrin, R. S. et al., Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects fromlethal acute GVHD. Blood 2005. 105: 2220-2226.
70. Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., Lucas, P. J., Gress, R. E., Levine, B. L., June, C. H. et al., L-selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004. 104: 3804-3812.
71. Wysocki, C. A., Jiang, Q., Panoskaltsis-Mortari, A., Taylor, P. A., McKinnon, K. P., Su, L., Blazar, B. R. and Serody, J. S., Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005. 106: 3300-3307.